Overview

Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)

Status:
Completed
Trial end date:
2015-09-28
Target enrollment:
Participant gender:
Summary
This study will evaluate biomarkers that reflect changes in gut mucosal status during therapy with infliximab and determine whether changes in the levels of the selected biomarkers can be used to predict endoscopically assessed gut mucosal status changes.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Infliximab